Albimmune SL
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Human Albumin Treatment in Adult Septic Shock. A Study Evaluating Immune Response and Organ Failure. (NCT05645887) | Albimmune SL | 2024-02-01 |
Track Albimmune SL automatically
Every clearance here is in the API, with alerts when new ones post.